Cablevision's support of The Lustgarten Foundation ensures that 100% of every donation goes directly to pancreatic cancer research.

Research Awards Listing

Research follows dollars, and The Lustgarten Foundation believes that increasing funds for pancreatic cancer research will translate into enhanced patient care, and ultimately, a cure.

The Lustgarten Foundation firmly believes that increasing funds for pancreatic cancer research is the surest path to improved patient care and eventually, to a cure. To date, we have committed nearly $110 million to providing the best and brightest minds with the resources to pursue the study and eradication of the disease.

View Award Listings by Year

2014  |  2013  |  2012  |  2011  |  2010  | 2009  |  2008  | 2007  |  2006  |  2005  |  2004  |  2003  |  2002  |  2001  |  2000-1998

1998 – 2000 Research Grants

Ashton University, United Kingdom
Michael J. Tisdale, DSc., Ph.D.
Mechanism of Muscle Protein Catabolism in Cancer Cachexia

Beth Israel Deaconess Medical Center
Hava Avraham Ph.D.
Studies of CHK Kinase in Pancreatic Cancer Cells

Creighton University School of Medicine
Thomas Adrian, Ph.D.
LOX Inhibitors for Pancreatic Cancer Treatment and Prevention

Duke University Medical Center
Douglas Tyler, M.D.
Immunotherapy of Pancreatic Cancer Using Dendritic Cells Pulsed with Antigen in the Form of Amplified Total Tumor R

Harvard School of Public Health
Eric J. Duell, Ph.D.
Gene-Environment Interactions in Pancreatic Adenocarcinoma

Johns Hopkins Medical Institutions
Michael G. Goggins, M.D.
Proteomic Profiles of Pancreatic Cancer

Johns Hopkins Medical Institutions
Constance Griffin, M.D.
Chromosome Analysis in Patients with Familial Pancreatic Cancer

Johns Hopkins Medical Institutions
Gloria Huei-Ting Su, Ph.D.
Mouse Models for Human Pancreatic Cancer

Johns Hopkins Medical Institutions
Elizabeth Jaffee, M.D.
A Phase II Study of an Allogeneic Gm-CSF Secreting Pancreatic Tumor Vaccine

Johns Hopkins Medical Institutions
Steven D. Leach, M.D.
Notch Signaling in Pancreatic Cancer Precursors

Mayo Clinic at Rochester
Gloria M. Peterson, Ph.D.
Genetic Epidemiology of Pancreatic Cancer

Memorial Sloan-Kettering Cancer Center
Yuman Fong, M.D.
Synergy of Herpes Viruses with Chemotherapy or Immunotherapy in the Treatment of Pancreatic Cancer

SUNY Downstate Medical Center
Josef Michl, M.D.
Matthew R. Pincus, M.D., Ph.D.
Novel Methods in the Diagnosis and Treatment of Pancreatic Cancer

University of Alabama at Birmingham
David T. Curiel, M.D.
Pancreatic Carcinoma Specific Replicative Adenoviral Agent

University of Texas M.D. Anderson Cancer Center
David McConkey, M.D.
Identifying Suitable Screening Tests to Detect Early Symptom-less Pancreatic Cancer

University of Texas M.D. Anderson Cancer Center
Keping Xie, M.D., Ph.D.
Control of Pancreatic Cancer Metastasis by Modulating Tumor-associated Nitric Oxide Production

University of California at San Francisco Comprehensive Cancer Center
Margaret Tempero, M.D.
Optimizing Therapy for Pancreatic Adenocarcinoma with TALL-104 Cells

University of Pittsburgh
David C. Whitcomb, M.D., Ph.D.
Identify Genes Which are Only Expressed in Pancreatic Cancer Cells

University of Texas at San Antonio
James Freeman, Ph.D.
TGF-B Type II Receptor Gene as a Target for the Antitumor Effect of Farnesyltransferace Inhibitors in Pancreatic Cancer

University of Texas M.D. Anderson Cancer Center
Robert Radinsky, Ph.D.
Blocking Tumor Growth Factor Receptors in Pancreatic Tumor Cells

University of Texas M.D. Anderson Cancer Center
Shrikanth A. G. Reddy, Ph.D.
AP-1 and Ras Signaling in Pancreatic Cancer Cells

* Collaborating Institution(s)

2015 website development and design sponsored by Celgene

1111 Stewart Avenue, Bethpage, New York 11714
Toll Free: 1-866-789-1000 P: 516-803-2304 F: 516-803-2303